Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Significance: Parkinson’s disease (PD) is a neurodegenerative disease linked to the misfolding and aggregation of a protein called “α-synuclein.” α-Synuclein aggregates found in the brains of PD patients are called “Lewy bodies” and “Lewy neurites.” We discovered the existence of a type of α-synuclein aggregate, smaller than previously described and conformationally distinct, that we called “pα-syn*.” Pα-syn* was present in neuronal cultures and mice brains injected with recombinant α-synuclein fibrils as well as in the brains of PD patients. We showed that pα-syn* is made of trimmed α-synuclein resulting from a failed cellular attempt to degrade fibrillar α-synuclein aggregates. We found that pα-syn* is a major neurotoxic species inducing mitochondrial damage, fission, and mitophagy, therefore constituting a central player in PD pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Similar to Aβ and Tau protein in AD, α-syn causes extensive damage when it becomes misfolded [130].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622 · cited 1×
“C-terminal truncations of α-syn by several proteases, such as calpain and cathepsin D, have been shown to promote fibrillization (35).”
BackgroundVolpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569 · cited 7×
“This form of pα-syn is known to be fibrillar (20, 23) and was named “pα-synF.”
BackgroundSelf-citationIn vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463
ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE
Olanow, C. W., & Tatton, W. G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.123 · Cited by 1,396
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins
Calvo, S. E., Clauser, K. R., & Mootha, V. K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1003 · Cited by 1,251
AMP-activated protein kinase mediates mitochondrial fission in response to energy stress
Toyama, E. Q., Herzig, S., Courchet, J., Lewis, T. L., Losón, O. C., Hellberg, K., Young, N. P., Chen, H., Polleux, F., Chan, D. C., et al. (2016) · Science · doi:10.1126/science.aab4138 · Cited by 1,085 · cited 1×
“Of note, AMPK has independently been found to mediate mitochondrial fission (44).”
BackgroundLuk, K. C., Song, C., O'Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 938 · cited 3×
“Discussion PFFs are internalized into neurons in culture, leading to the recruitment of endogenous α-syn and the progressive accumulation of pα-syn inclusions reminiscent of LBs and LNs (herein called pα-synF) (14, 20).”
BackgroundT cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Management of cellular energy by the AMP‐activated protein kinase system
Hardie, D. G., Scott, J. W., Pan, D. A., & Hudson, E. R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00560-x · Cited by 855
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Danzer, K. M., Kranich, L. R., Ruf, W. P., Cagsal-Getkin, O., Winslow, A. R., Zhu, L., Vanderburg, C. R., & McLean, P. J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-42 · Cited by 853 · cited 1×
“The role of exosomes as vectors of intercellular communication and material exchange is a fascinating area of biology, and exosomes contribute to the propagation of misfolded proteins and α-syn oligomers in particular (47).”
BackgroundHansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
Volpicelli-Daley, L. A., Luk, K. C., & Lee, V. M.-Y. (2014) · Nature Protocols · doi:10.1038/nprot.2014.143 · Cited by 731 · cited 1×
“Notably, fibrils of recombinant α-syn, called “preformed fibrils” (PFFs), seed the misfolding and aggregation of endogenous α-syn in cell lines and primary neurons, leading to the formation of large Triton-insoluble α-syn fibrils (14, 19, 20).”
BackgroundSelf-citationα-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
Prusiner, S. B., Woerman, A. L., Mordes, D. A., Watts, J. C., Rampersaud, R., Berry, D. B., Patel, S., Oehler, A., Lowe, J. K., Kravitz, S. N., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514475112 · Cited by 689 · cited 1×
“Recently, the concept has emerged of the existence of different “strains” of α-syn aggregates by analogy to prions, which are aggregates of misfolded prion protein (54, 55).”
BackgroundDistinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Guo, J. L., Covell, D. J., Daniels, J. P., Iba, M., Stieber, A., Zhang, B., Riddle, D. M., Kwong, L. K., Xu, Y., Trojanowski, J. Q., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.057 · Cited by 680 · cited 1×
“Recently, the concept has emerged of the existence of different “strains” of α-syn aggregates by analogy to prions, which are aggregates of misfolded prion protein (54, 55).”
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
Di Maio, R., Barrett, P. J., Hoffman, E. K., Barrett, C. W., Zharikov, A., Borah, A., Hu, X., McCoy, J., Chu, C. T., Burton, E. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3634 · Cited by 619 · cited 1×
“A previous study also showed that a phosphomimetic mutant of α-syn, S129E, binds to Tom20 and inhibits mitochondrial protein import (42).”
BackgroundKudo, N., Barr, A. J., Barr, R. L., Desai, S., & Lopaschuk, G. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17513 · Cited by 564 · cited 1×
“ACC1 is inactivated by phosphorylation (30).”
Pendergrass, W., Wolf, N., & Poot, M. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20033 · Cited by 473
There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439
Recent Advances in the Genetics of Parkinson's Disease
Martin, I., Dawson, V. L., & Dawson, T. M. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101440 · Cited by 437
Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 426 · cited 1×
“For example, JNK activation has been shown to be involved in mitochondrial dysfunction and dopaminergic cell loss in animal models of neurodegeneration (45, 46).”
BackgroundOueslati, A. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160779 · Cited by 375 · cited 10×
“These fibrils are composed of α-syn phosphorylated at S129 (pα-syn), mimicking the formation of LBs in PD patients’ brains where >90% of α-syn is phosphorylated at S129 (21).”
BackgroundInfluentialNew functions of mitochondria associated membranes in cellular signaling
van Vliet, A. R., Verfaillie, T., & Agostinis, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.03.009 · Cited by 353 · cited 10×
“Pα-syn* was found in the vicinity of mitochondria-associated endoplasmic reticulum (ER) membranes (MAMs) known to juxtapose to the sites of mitochondrial fission and mitophagy.”
BackgroundInfluentialImpaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
Büeler, H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.006 · Cited by 327 · cited 1×
“On the other hand, there is overwhelming evidence for the involvement of mitochondrial pathology in PD (39, 40).”
BackgroundLewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy
Tanik, S. A., Schultheiss, C. E., Volpicelli-Daley, L. A., Brunden, K. R., & Lee, V. M. Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.457408 · Cited by 326 · cited 2×
“Pα-syn aggregates persist despite colocalizing with components of the autophagic and proteasomal protein degradation machineries; thus it has been suggested that the aggregates are refractory to clearance (22).”
BackgroundSelf-citationCytochrome c release from mitochondria: all or nothing
Martinou, J.-C., Desagher, S., & Antonsson, B. (2000) · Nature Cell Biology · doi:10.1038/35004069 · Cited by 318 · cited 2×
“Cytochrome C accumulation occurs after mitochondrial inner membrane depolarization, and its release is thought to follow outer membrane permeabilization (25, 26).”
BackgroundEffect of Nebulized Ipratropium on the Hospitalization Rates of Children with Asthma
Qureshi, F., Pestian, J., Davis, P., & Zaritsky, A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391503 · Cited by 294
Ubiquitin-independent proteasomal degradation
Erales, J., & Coffino, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.008 · Cited by 243 · cited 1×
“Indeed the 20S proteasomal subunit by itself has limited and nonspecific proteolytic activity in an ubiquitin-independent fashion (37).”
BackgroundIn Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers
Simoneau, S., Rezaei, H., Salès, N., Kaiser-Schulz, G., Lefebvre-Roque, M., Vidal, C., Fournier, J.-G., Comte, J., Wopfner, F., Grosclaude, J., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030125 · Cited by 240
Self-citationArima, K., Uéda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H., & Kawai, M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050917 · Cited by 239
Volpicelli-Daley, L. A., Gamble, K. L., Schultheiss, C. E., Riddle, D. M., West, A. B., & Lee, V. M.-Y. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-02-0741 · Cited by 232 · cited 3×
“PFF seeding of neurons has been shown to induce adverse effects such as defective vesicular transport (23), elevated dendritic mitochondrial oxidant stress (38), and synaptic dysfunction and neuronal death (20).”
BackgroundSelf-citationDryanovski, D. I., Guzman, J. N., Xie, Z., Galteri, D. J., Volpicelli-Daley, L. A., Lee, V. M. Y., Miller, R. J., Schumacker, P. T., & Surmeier, D. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5311-12.2013 · Cited by 212 · cited 1×
“PFF seeding of neurons has been shown to induce adverse effects such as defective vesicular transport (23), elevated dendritic mitochondrial oxidant stress (38), and synaptic dysfunction and neuronal death (20).”
BackgroundSelf-citationReeve, A. K., Ludtmann, M. H., Angelova, P. R., Simcox, E. M., Horrocks, M. H., Klenerman, D., Gandhi, S., Turnbull, D. M., & Abramov, A. Y. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.166 · Cited by 198 · cited 1×
“These observations are in agreement with previous findings that cell treatment with aggregated α-syn leads to impairment of complex I of the electron transport chain and to reduced ATP and increased ROS production (41).”
ResultZhang, Z., Kang, S. S., Liu, X., Ahn, E. H., Zhang, Z., He, L., Iuvone, P. M., Duong, D. M., Seyfried, N. T., Benskey, M. J., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3433 · Cited by 195 · cited 1×
“Recently, an endolysosomal protease, asparagine endopeptidase, has been shown to cleave α-syn N-terminally in the brain of PD patients and to be involved in the pathogenesis of the disease (36).”
BackgroundAthanassiadou, A., Voutsinas, G. E., Psiouri, L., Leroy, E., Polymeropoulos, M. H., Ilias, A., Maniatis, G. M., & Papapetropoulos, T. (1999) · The American Journal of Human Genetics · doi:10.1086/302486 · Cited by 126
Gene dosage and pathogenesis of Parkinson's disease
Eriksen, J. L., Przedborski, S., & Petrucelli, L. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.01.001 · Cited by 122
α-Synuclein and Lewy pathology in Parkinson's disease
Kalia, L. V., & Kalia, S. K. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000215 · Cited by 92 · cited 1×
“However, there was a need to identify toxic conformations of α-syn and define their relationship to Lewy pathology (56).”
BackgroundBUSTAMANTE, J., Nutt, L. K., Orrenius, S., & Gogvadze, V. G. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.024 · Cited by 87 · cited 2×
“Cytochrome C accumulation occurs after mitochondrial inner membrane depolarization, and its release is thought to follow outer membrane permeabilization (25, 26).”
BackgroundChambers, J. W., Howard, S., & LoGrasso, P. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.421354 · Cited by 74 · cited 1×
“For example, JNK activation has been shown to be involved in mitochondrial dysfunction and dopaminergic cell loss in animal models of neurodegeneration (45, 46).”
BackgroundSelf-citationMackenzie, R. M., Salt, I. P., Miller, W. H., Logan, A., Ibrahim, H. A., Degasperi, A., Dymott, J. A., Hamilton, C. A., Murphy, M. P., Delles, C., et al. (2013) · Clinical Science · doi:10.1042/cs20120239 · Cited by 67
Douglas, D. N., Pu, C. H., Lewis, J. T., Bhat, R. K., Anwar‐Mohamed, A., Logan, M. R., Lund, G. A., Addison, W. R., Lehner, R. S., & Kneteman, N. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.674861 · Cited by 48
Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
Raiss, C. C., Braun, T., Konings, I. B. M., Grabmayr, H., Hassink, G. C., Sidhu, A., le Feber, J., Bausch, A. R., Jansen, C., Subramaniam, V., et al. (2016) · Scientific Reports · doi:10.1038/srep23116 · Cited by 39 · cited 1×
“The involvement of pα-syn in PD pathology was recognized exactly two decades ago (10), and numerous studies have examined the morphology and localization of α-syn aggregates (14, 53).”
BackgroundMonteuuis, G., Suomi, F., Kerätär, J. M., Masud, A. J., & Kastaniotis, A. J. (2017) · Biochemical Journal · doi:10.1042/bcj20170416 · Cited by 36 · cited 3×
“The activity of mitochondrial ACC1 is necessary for fatty acid synthesis and mitochondrial biogenesis (31).”
BackgroundInfluentialZhao, F., Bi, L., Wang, W., Wu, X., Li, Y., Gong, F., Lu, S., Feng, F., Qian, Z., Hu, C., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.007 · Cited by 33 · cited 1×
“At least five genes, SNCA, GBA, PARK2/Parkin, PINK1, DJ-1, and LRRK2, are linked to heritable PD (4, 5).”
BackgroundErpapazoglou, Z., & Corti, O. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150008 · Cited by 19 · cited 3×
“MAMs are the sites of initiation of mitochondrial fission and Parkin-regulated mitophagy (33, 34).”
BackgroundFailures and Successes of Clinical Trials for Parkinson Disease Treatments
Dawson, T. M. (2005) · Retina · doi:10.1097/00006982-200512001-00036 · Cited by 2 · cited 1×
“There is currently no disease-modifying treatment for PD (3).”
BackgroundPrice (1999) · doi:10.1002/1531-8249(199903)45:3
Research works printed but not linked: 1
- 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4 · doi:10.1002/1531-8249(199903)45:3<353::aid-ana11>3.0.co;2-4
Cited by
Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
Shahmoradian, S. H., Lewis, A. J., Genoud, C., Hench, J., Moors, T. E., Navarro, P. P., Castaño-Díez, D., Schweighauser, G., Graff-Meyer, A., Goldie, K. N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0423-2 · Cited by 996
The machineries, regulation and cellular functions of mitochondrial calcium
Giorgi, C., Marchi, S., & Pinton, P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0052-8 · Cited by 941
Mahul-Mellier, A.-L., Burtscher, J., Maharjan, N., Weerens, L., Croisier, M., Kuttler, F., Leleu, M., Knott, G. W., & Lashuel, H. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913904117 · Cited by 710
“For the most part, classification of α-syn aggregates as having LB-like features has been limited to very few biomarkers (8–10), namely pS129, ub, and p62 immunoreactivity and the detection of HMW aggregates in Western blotting (8, 21, 32, 33).”
BackgroundResultInfluentialPINK1/PARKIN signalling in neurodegeneration and neuroinflammation
Quinn, P. M. J., Moreira, P. I., Ambrósio, A. F., & Alves, C. H. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01062-w · Cited by 481
Lipogenesis inhibitors: therapeutic opportunities and challenges
Batchuluun, B., Pinkosky, S. L., & Steinberg, G. R. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00367-2 · Cited by 399
Metadata
- Authors
- Grassi, D., Howard, S., Zhou, M., Diaz-Perez, N., Urban, N. T., Guerrero-Given, D., Kamasawa, N., Volpicelli-Daley, L. A., LoGrasso, P., & Lasmézas, C. I.
- Affiliations
- Scripps Research Institute (US)
- Private address, Palm Beach Gardens, FL 33418;
- Max Planck Florida Institute for Neuroscience (US)
- Electron Microscopy Facility, Max Planck Florida Institute for Neuroscience, Jupiter, FL 33458;
- Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-02-27
- Volume
- 115
- Issue
- 11
- Pages
- E2634-E2643
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5856519
- OpenAlex
- W2791533445
- Cited by
- 228
- References
- 58
- Citations by year
- 2026: 18 · 2025: 17 · 2024: 17 · 2023: 16 · 2022: 34 · 2021: 38 · 2020: 44 · 2019: 30 · 2018: 14
- FWCI
- 21.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS085223)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- alpha-synuclein, Parkinson's disease, phosphorylated alpha-synuclein, mitophagy, mitochondrial fragmentation, mitochondrial depolarization, cytochrome c release, acetyl-CoA carboxylase 1, AMPK, lipoylation, BiP, unfolded protein response, autophagy, neurotoxicity, Lewy bodies, therapeutic target
- MeSH terms
- Acetyl-CoA Carboxylase, Animals, Autophagy, Brain, Brain Chemistry, Cells, Cultured, Humans, Lysosomes, Mitochondria, Neurotoxins, Parkinson Disease, Phosphorylation, Oxidative Stress, Cell Culture Techniques, Mice, alpha-Synuclein, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.